The journal highlights their reduction of cardiovascular incidents and the possibilities they create for treating conditions as diverse as addictions, Alzheimer’s disease and Parkinson’s disease
The pharmaceutical company Novo Nordisk, which manufactures Ozempic and Wegovy, says that these medications minimize cardiovascular diseases in overweight people